PLDT (NYSE:PHI) Stock, Quote.Headers.trade-ideas

PLDT

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line, and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACAD

AEVA

ASAN

LXRX

OCUL

XPDB

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday&#39;s Pre-Market Session

Short Ideas

BBGI

FLNT

As of Jan. 12, 2024, four stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 4 Tech And Telecom Stocks That May Crash In January

Asset Sales

Media


	Philippines’ largest telecommunications firm PLDT Inc (NYSE: PHI), weighed the sale of a significant minority stake in its data center assets as it battled fallout from a spending scandal.


PLDT Explores Stake Sale In Data Center Assets To Raise Cash For Business Development

PLDT Inc

PHI Group Inc

Phinia Inc

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corp

PHASE HOLOGRAPHIC IMAGNG by Phase Holographic Imaging PHI AB

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
Shares of ACADIA Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acad#NASDAQ">ACAD</a>) fell sharply in today&rsquo;s pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not <a href="https://www.benzinga.com/quote/ACAD/news">meet the primary endpoint</a>.
ACADIA Pharmaceuticals shares dipped 17.4% to $19.93 in pre-market trading.
Here are some big stocks recording losses in today&rsquo;s pre-market trading session.
<ul>
<li>Power &amp; Digital Infrastructure Acquisition II Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpdb#NASDAQ">XPDB</a>) shares tumbled 12.6% to $25.57 in pre-market trading after surging 181% on Monday.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) shares fell 5.9% to $9.16 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Aeva Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeva#NASDAQ">AEVA</a>) shares declined 5.4% to $1.23 in pre-market trading. Aeva said it expects a 1-for-5 reverse stock split of its outstanding shares of common stock will be effective as of March 18, 2024.</li>
<li>PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>) fell 3.8% to $25.95 in pre-market trading after jumping over 16% on Monday.</li>
<li>NextNav Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nn#NASDAQ">NN</a>) declined 3.6% to $5.07 in pre-market trading. NextNav shares jumped 35% on Monday after the company announced it signed an agreement to acquire spectrum licenses covering an additional 4 MHz in the lower 900 MHz band.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) shares fell 3.2% to $2.72 in pre-market trading. Lexicon shares surged over 29% on Monday after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.</li>
<li>Asana, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asan#NYSE">ASAN</a>) shares fell 2.4% to $18.35 in pre-market trading following fourth-quarter results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37584146/top-5-risk-off-stocks-that-may-plunge-this-quarter"> Top 5 Risk Off Stocks That May Plunge This Quarter </a>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

ASNA

ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

As of Jan. 12, 2024, four stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Beasley Broadcast Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbgi#NASDAQ">BBGI</a>)</h3>
<ul>
<li>On Nov. 1, Beasley Broadcast posted downbeat quarterly results. Caroline Beasley, Chief Executive Officer, said, &ldquo;Beasley&rsquo;s third quarter financial results reflect the well-publicized economic challenges and continued advertising market softness which we outlined in the prior quarters. While we saw sequential month-over-month improvement in our advertising revenue performance from August to September, our net revenues for the 2023 third quarter decreased 5.8% year-over-year, or 3.2% when excluding the year-over-year decrease in political advertising revenue of $1.9 million.&rdquo; The company&rsquo;s stock jumped around 7% over the past month and has a <a href="https://www.benzinga.com/quote/BBGI">52-week high of $1.39 </a>.</li>
<li>RSI Value: 75.48</li>
<li>BBGI Price Action: Shares of Beasley Broadcast fell 1.9% to close at $0.8050 on Thursday.</li>
</ul>
<h3>Fluent, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flnt#NASDAQ">FLNT</a>)</h3>
<ul>
<li>On Nov. 14, 2023, Fluent posted weak quarterly results. Don Patrick, Fluent&rsquo;s Chief Executive Officer, commented, &ldquo;Our third quarter results clearly reflect our post-FTC settlement transition and the subsequent impact on our financials related to the business segments we have deemed non-strategic in the future.&rdquo; The company&rsquo;s stock gained around 45% over the past month and <a href="https://www.benzinga.com/quote/FLNT"> has a 52-week high </a> of $1.81.</li>
<li>RSI Value: 78.11</li>
<li>FLNT Price Action: Shares of Fluent fell 2.5% to close at $0.7401 on Thursday.</li>
</ul>
<h3>Reading International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdi#NASDAQ">RDI</a>)</h3>
<ul>
<li>On Nov. 14, Reading International posted a narrower quarterly loss. President and Chief Executive Officer, Ellen Cotter said, &ldquo;Building on the success of our strong second quarter, the Company continued that positive momentum into the third quarter by delivering global total revenues of $66.6 million, which grew by 30% compared to the third quarter of 2022.&rdquo; The company&rsquo;s stock jumped around 13% over the past month and has a <a href="https://www.benzinga.com/quote/RDI"> 52-week high </a> of $3.72.</li>
<li>RSI Value: 70.78</li>
<li>RDI Price Action: Shares of Reading International rose 1% to close at $1.98 on Thursday.</li>
</ul>
<h3>PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>)</h3>
<ul>
<li>The company&rsquo;s stock has a 52-week high is $27.98.</li>
<li>RSI Value: 70.60</li>
<li>PHI Price Action: Shares of PLDT fell 1% to close at $22.94 on Thursday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/01/36606238/citigroup-bank-of-america-and-3-stocks-to-watch-heading-into-friday"> Citigroup, Bank of America And 3 Stocks To Watch Heading Into Friday </a>

<ul>
<li>Philippines&rsquo; largest telecommunications firm&nbsp;PLDT Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>), weighed the sale of a significant minority stake in its data center assets as it battled fallout from a spending scandal.</li>
<li>PLDT eyed selling telecom towers in 2023 to offset the impact of the capital spending exceeding its budget, Bloomberg&nbsp;<a class="editor-rtfLink" href="https://www.bloomberg.com/news/articles/2023-02-23/pldt-said-to-weigh-data-center-stake-sale-after-spending-overrun?srnd=technology-vp&amp;sref=TBDibEcD" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">reports</a>&nbsp;citing familiar sources.&nbsp;</li>
<li>PLDT consulted financial advisers as it weighs bringing in an investor into its data center business.&nbsp;</li>
<li>A transaction could value the business at $700 million - $800 million.</li>
<li>A partner would help the company raise cash and further develop its business.&nbsp;</li>
<li>In 2022, PLDT sold half its telecom towers for about $1.3 billion in two portfolios to Edotco Group Sdn. and EdgePoint Infrastructure units. It&rsquo;s also considering selling a few thousand towers for about $300 million.</li>
<li>PLDT had weighed a sale of the data centers in 2021 before putting the process on hold.</li>
<li>PLDT did not consider a stake sale &ldquo;as of the moment,&rdquo; Mitch Locsin, PLDT&rsquo;s first vice president and head of the enterprise, said in response to a Bloomberg query. He added that the company&rsquo;s information technology unit focused on completing its hyperscaler 11th data center.</li>
<li>PLDT grappled with local investigations and a U.S. shareholder lawsuit related to a 48 billion peso ($871 million) spending overrun discovered in an internal audit last year.</li>
<li>Price Action:&nbsp;PHI shares traded lower by 0.77% at $24.34 on the last check Thursday.</li>
</ul>

<h3>Understanding Value Stocks</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Benzinga Insights has compiled a list of value stocks in the communication services sector that may be worth watching:</h2>
<ol>
<li>Gogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOGO#NASDAQ">GOGO</a>) - P/E: 6.96</li>
<li>Urban One (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UONEK#NASDAQ">UONEK</a>) - P/E: 5.7</li>
<li>Outbrain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OB#NASDAQ">OB</a>) - P/E: 5.74</li>
<li>JOYY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) - P/E: 4.92</li>
<li>PLDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHI#NYSE">PHI</a>) - P/E: 8.37</li>
</ol>
Gogo saw a decrease in earnings per share from 0.17 in Q2 to $0.15 now. Urban One's earnings per share for Q3 sits at $0.08, whereas in Q2, they were at 0.28. Outbrain has reported Q3 earnings per share at $-0.1, which has increased by 47.37% compared to Q2, which was -0.19. Most recently, the company reported a dividend yield of 4.61%, which has decreased by 1.91% from last quarter's yield of 6.52%.
This quarter, JOYY experienced an increase in earnings per share, which was $0.65 in Q2 and is now $0.96. The company's most recent dividend yield sits at 7.52%, which has increased by 1.23% from 6.29% last quarter. 
This quarter, PLDT experienced an increase in earnings per share, which was $0.67 in Q2 and is now $0.87. The company's most recent dividend yield sits at 8.77%, which has increased by 5.4% from 3.37% last quarter. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

GOGO

UONEK

5 Value Stocks In The Communication Services Sector

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>The Liberty SiriusXM Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lsxmk#NASDAQ">LSXMK</a>)</h3>
<ul>
<li>Liberty Media said Courtnee Chun, currently Chief Portfolio Officer, will transition to a Senior Advisor role effective January 3, 2023. The company&rsquo;s stock has a <a href="https://www.benzinga.com/news/earnings/22/05/27048973/liberty-media-boosts-share-buyback-post-q1-liberty-siriusxm-clocks-6-revenue-growth-to-2-2b">52-week low of $34.34 </a>.</li>
<li>RSI Value: 29.68</li>
<li>LSXMK Price Action: Shares of Liberty SiriusXM rose 1.2% to settle at $39.02 on Wednesday.</li>
</ul>
<h3>
PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>)</h3>
<ul>
<li>PLDT&rsquo;s stock dropped around 18% over the past month. The company&rsquo;s <a href="https://www.benzinga.com/news/22/12/30133347/why-cosmos-health-shares-are-trading-lower-by-around-60-here-are-79-stocks-moving-in-mondays-mid-day"> stock has a 52-week low </a> of $20.20.</li>
<li>RSI Value: 27.80</li>
<li>PHI Price Action: Shares of PLDT gained 9.2% to close at $22.66 on Wednesday and lost 2.4% in after-hours trading.</li>
</ul>
<h3>
Cinemark Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnk#NYSE">CNK</a>)</h3>
<ul>
<li>Benchmark maintained Cinemark with a Buy and lowered the price target from $22 to $17. The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/news/earnings/22/11/29571137/cinemark-clocks-positive-operating-income-in-q3-as-recovery-kicks-in-registers-50-revenue-growth"> low of $8.90.</a></li>
<li>RSI Value: 27.13</li>
<li>CNK Price Action: Shares of Cinemark Holdings fell 2.8% to close at $8.95 on Wednesday and gained 1.1% in after-hours trading.</li>
</ul>
<h3>
The Marcus Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mcs#NYSE">MCS</a>)</h3>
<ul>
<li>Marcus Hotels &amp; Resorts. <a href="https://www.benzinga.com/markets/penny-stocks/22/12/30059460/short-interest-sector-focus-communication-services-sector"> announced the sale of </a> Skirvin Hilton for $36.75 million. The company&rsquo;s 52-week low is $13.41.</li>
<li>RSI Value: 29.29</li>
<li>MCS Price Action: Shares of Marcus dropped 1% to close at $14.00 on Wednesday.</li>
</ul>
<h3>
AST SpaceMobile, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asts#NASDAQ">ASTS</a>)</h3>
<ul>
<li>AST SpaceMobile and NASA signed a joint agreement to improve spaceflight safety. The company <a href="https://www.benzinga.com/news/22/11/29904240/ast-spacemobile-raises-75m-via-equity-offering"> has a 52-week low </a> of $3.63.</li>
<li>RSI Value: 26.06</li>
<li>ASTS Price Action: Shares of AST SpaceMobile gained 2.5% to settle at $3.77 on Wednesday, and added 0.3% in the after-hours trading session.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/earnings/22/12/30170537/cnn-fear-greed-index-remains-in-fear-zone-despite-dow-jumping-over-500-points"> CNN Fear &amp; Greed Index Remains In &#39;Fear&#39; Zone Despite Dow Jumping Over 500 Points </a>

Long Ideas

ASTS

LSXMK

Why Cinemark, Liberty SiriusXM And Other Oversold Majors In The Communication Services Sector Look Promising

WIIM

CHTR

EVER

GROM

IPDN

LFLY

LILA

LILAK

LTRPB

MGAM

MSGS

NFLX

PINS

SNAP

STRY

TRKA

Shares of several companies in the broader communications, media & entertainment industry are trading higher amid overall market weakness as stocks rebound following recent weakness.

BHAT

BMBL

DLPN

FOXA

ICLK

LSXMB

LYLT

MTCH

NCMI

NXST

ONFO

PLTK

SKLZ

VTEX

WLYB

YNDX

Shares of several companies in the broader communication, media and entertainment industry are trading lower amid overall market weakness as investors continue to weigh recession fears following last Wednesday's Fed decision, in which the Fed raised rates and increased its federal funds rate projections.

<h3>Gainers</h3>
<ul>
<li>Madrigal Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgl#NASDAQ">MDGL</a>) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.</li>
<li>Axcella Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axla#NASDAQ">AXLA</a>) shares rose 153% to $0.4105. Axcella Health shares dipped 63% on Friday after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered its price target from $6 to $2.</li>
<li>Camber Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cei#NYSE">CEI</a>) shares climbed 103% to $0.1257 after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split.</li>
<li>Qumu Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qumu#NASDAQ">QUMU</a>) gained 98.2% to $0.8722 after Enghouse Systems announced it will acquire the company for $0.90 per share in cash.</li>
<li>AirNet Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ante#NASDAQ">ANTE</a>) jumped 64% to $1.93.</li>
<li>Viking Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vktx#NASDAQ">VKTX</a>) shares climbed 61% to $6.48 in sympathy with Madrigal Pharmaceuticals which announced a successful trial for liver fibrosis.</li>
<li>Nogin, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nogn#NASDAQ">NOGN</a>) rose 44% to $0.72 after declining 39% on Friday. Nogin&rsquo;s Co-CEO and President Jonathan Huberman recently acquired a total of 19,300 shares at an average price of $0.90.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slno#NASDAQ">SLNO</a>) surged 39% to $1.26 after the company announced a financing commitment for up to $60 million.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) rose 39% to $9.55 in sympathy with Madrigal Pharmaceuticals, which gained after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.</li>
<li>Caravelle International Group (NASDAQ: CACO) gained 38.8% to $5.83.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) climbed 38% to $0.3410 after dipping around 70% on Friday. Agrify announced pricing of a public offering.</li>
<li>Innate Pharma S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipha#NASDAQ">IPHA</a>) rose 37% to $2.6032 after the company and Sanofi announced an expansion of their collaboration for natural killer cell therapeutics in oncology. Innate will receive a &euro;25 million upfront payment.</li>
<li>Greenidge Generation Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gree#NASDAQ">GREE</a>) rose 30.3% to $0.3260 after dropping 39% on Friday.</li>
<li>Cazoo Group Ltd (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/czoo#NYSE">CZOO</a>) rose 24.4% to $0.1618. Cazoo recently sold its Spanish subscription business, Swipcar, to Renting Finders S.L.</li>
<li>Otonomy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otic#NASDAQ">OTIC</a>) rose 24.1% to $0.1118 after dropping over 21% on Friday.</li>
<li>Cerevel Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cere#NASDAQ">CERE</a>) gained 24% to $31.53 after the company said its Emraclidine Ambulatory Blood Pressuring Monitoring Trial did not cause an increase in blood pressure.</li>
<li>Aspen Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aspu#NASDAQ">ASPU</a>) gained 23.3% to $0.2833. Aspen Group recently reported better-than-expected Q2 sales results.</li>
<li>iHuman Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ih#NYSE">IH</a>) gained 21.2% to $2.80.</li>
<li>Anebulo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aneb#NASDAQ">ANEB</a>) gained 20.3% to $2.84.</li>
<li>Future FinTech Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftft#NASDAQ">FTFT</a>) jumped 19.1% to $0.5480.</li>
<li>Celcuity Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/celc#NASDAQ">CELC</a>) gained 19% to $11.91.</li>
<li>AppHarvest, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apph#NASDAQ">APPH</a>) rose 18.7% to $0.5563.</li>
<li>Troika Media Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) rose 17.8% to $0.1178 after dropping around 6% on Friday.</li>
<li>Bird Global, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brds#NYSE">BRDS</a>) gained 17.7% to $0.1765.</li>
<li>Professional Diversity Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipdn#NASDAQ">IPDN</a>) surged 17.6% to $0.7771.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) rose 17.5% to $0.45 after declining 21% on Friday.</li>
<li>Horizon Global Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzn#NYSE">HZN</a>) gained 16.7% to $0.70.</li>
<li>PainReform Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prfx#NASDAQ">PRFX</a>) gained 14% to $0.57.</li>
<li>Akili, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akli#NASDAQ">AKLI</a>) shares rose 14% to $1.14 after dipping 35% on Friday.</li>
<li>CI&amp;T Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cint#NYSE">CINT</a>) gained 12.8% to $5.89. CI&amp;T said that it has become an Amazon Web Services (AWS) Advanced Tier Services Partner within the AWS Partner Network.</li>
<li>Coeptis Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coep#NASDAQ">COEP</a>) rose 11.6% to $1.15 after dropping 36% on Friday.</li>
<li>Reading International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdib#NASDAQ">RDIB</a>) gained 10.2% to $19.77.</li>
<li>17 Education &amp; Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yq#NASDAQ">YQ</a>) rose 10.2% to $1.8286 after jumping 29% on Friday. 17 Education &amp; Technology recently posted a Q3 loss of $0.01 per share.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) gained 10% to $3.9699.</li>
<li>Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) gained 8.4% to $7.10.</li>
<li>ObsEva SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/obsv#NASDAQ">OBSV</a>) rose 6.6% to $0.1472. The company reported dismissal of moratorium proceedings.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>Cosmos Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cosm#NASDAQ">COSM</a>) shares dipped 59.6% to $9.30 after the company reported pricing of $32.5 million registered direct offering and concurrent private placement priced at-the-market.</li>
<li>Forward Pharma A/S (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwp#NASDAQ">FWP</a>) fell 38.7% to $1.60. Forward Pharma announced expected delisting of its American Depositary Shares from the Nasdaq Capital Market.</li>
<li>Scopus BioPharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/scps#NASDAQ">SCPS</a>) fell 34.7% to $0.0556.</li>
<li>NantHealth, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nh#NASDAQ">NH</a>) fell 30.7% to $3.95. NantHealth recently announced a 1-for-15 reverse stock split.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) dropped 25.1% to $2.4109.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) declined 25% to $0.1092. VistaGen Therapeutics recently announced the FDA granted Fast Track designation for the development of PH10 for the treatment of major depressive disorder.</li>
<li>Invacare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ivc#NYSE">IVC</a>) dropped 25% to $0.4499.</li>
<li>Healthcare Triangle, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcti#NASDAQ">HCTI</a>) fell 23.7% to $0.2364.</li>
<li>Lanvin Group Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lanv#NYSE">LANV</a>) fell 23% to $7.70 after surging 31% on Friday.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) dropped 22.8% to $0.27. Neptune Wellness Solutions reported a net loss of $37.3 million for the fiscal second quarter 2023 versus a year-ago net loss of $12.1 million. Its net sales revenue declined to $12 million from $12.5 million.</li>
<li>PLDT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>) dropped 22.4% to $20.81.</li>
<li>BiomX Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phge#NYSE">PHGE</a>) shares fell 22.1% to $0.1720 after jumping 63% on Friday. BiomX, last month, posted a Q3 loss of $0.23 per share.</li>
<li>Tellurian Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tell#NASDAQ">TELL</a>) dropped 20.3% to $1.93.</li>
<li>Gossamer Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goss#NASDAQ">GOSS</a>) declined 20.3% to $2.1750.</li>
<li>Akero Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akro#NASDAQ">AKRO</a>) fell 18.9% to $38.10.</li>
<li>Intercept Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icpt#NASDAQ">ICPT</a>) fell 18.8% to $12.45. STAT News reporter Adam Feuerstein tweets &quot;Intercept Pharmaceuticals Down 10% Because OCA&#39;s Future In NASH Looks Bleaker. Investors Really Want Intercept To Ditch NASH And Focus On The Approved PBC Indication.&quot;</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) dropped 17.9% to $0.5598.</li>
<li>Meihua International Medical Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mhua#NASDAQ">MHUA</a>) fell 17.8% to $9.28.</li>
<li>Nexa Resources S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nexa#NYSE">NEXA</a>) dropped 17.8% to $5.51.</li>
<li>Altimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alt#NASDAQ">ALT</a>) fell 17.2% to $9.51.</li>
<li>89bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etnb#NASDAQ">ETNB</a>) fell 16.8% to $8.78.</li>
<li>Vivani Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vani#NASDAQ">VANI</a>) dropped 16.7% to $0.8578.</li>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) fell 16.5% to $0.1773 after jumping 22% on Friday.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) dropped 15.7% to $4.24.</li>
<li>Synaptogenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpx#NASDAQ">SNPX</a>) fell 14.3% to $1.0228. Synaptogenix shares dropped 75% on Friday after the company announced results from its Phase 2 clinical trial of Bryostatin-1 for the treatment of advanced Alzheimer&#39;s disease, in which the primary endpoint was not met with statistical significance.</li>
<li>Cue Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlth#NASDAQ">HLTH</a>) fell 14.2% to $2.5050.</li>
<li>C4 Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cccc#NASDAQ">CCCC</a>) dropped 14.1% to $6.32.</li>
<li>Seer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seer#NASDAQ">SEER</a>) declined 13.6% to $5.40.</li>
<li>New Pacific Metals Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newp#NYSE">NEWP</a>) fell 13.4% to $2.50.</li>
<li>Mondee Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mond#NASDAQ">MOND</a>) dropped 13.4% to $10.61.</li>
<li>Arcellx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aclx#NASDAQ">ACLX</a>) fell 12.2% to $27.97.</li>
<li>Richardson Electronics, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rell#NASDAQ">RELL</a>) dropped 11.6% to $21.66.</li>
<li>Gevo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gevo#NASDAQ">GEVO</a>) fell 10.7% to $1.7950.</li>
<li>Cinemark Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnk#NYSE">CNK</a>) fell 10.5% to $9.69.</li>
<li>Domo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) dropped 10.5% to $14.81. Morgan Stanley maintained Domo with an Overweight and lowered the price target from $51 to $24.</li>
<li>Mersana Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrsn#NASDAQ">MRSN</a>) dipped 10.5% to $5.82.</li>
<li>ChargePoint Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chpt#NYSE">CHPT</a>) declined 9.6% to $9.45.</li>
<li>MasterBrand, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mbc#NYSE">MBC</a>) fell 9.5% to $8.42 after jumping over 20% on Friday.</li>
<li>Relay Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rlay#NASDAQ">RLAY</a>) dropped 9.4% to $15.44.</li>
<li>Melco Resorts &amp; Entertainment Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlco#NASDAQ">MLCO</a>) fell 9.3% to $10.90.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) dropped 8.3% to $4.8650. AMC Entertainment announced Monday that it has raised $162 million from its AMC Preferred Equity Units since launching the stock just a few months ago.</li>
<li>Ardelyx, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ardx#NASDAQ">ARDX</a>) fell 7.9% to $1.8050 after the company provided an update regarding the appeal to the Complete Response Letter for the New Drug Application for XPHOZAH.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) fell 7.8% to $0.2787. Mullen Automotive recently announced it received a purchase order from Randy Marion Automotive Group for 6,000 Class 1 EV cargo vans.</li>
</ul>
Also check this out <a href="https://www.benzinga.com/trading-ideas/long-ideas/22/12/30127835/over-13-million-bet-on-this-biotechnology-stock-check-out-these-4-stocks-insiders-are-bu"> Over $13 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying</a>.

Intraday Update

ACLX

AGFY

AKLI

AKRO

ANEB

ANTE

APPH

ARBK

ARDX

ASPU

AXLA

BRDS

CCCC

CELC

CERE

CHPT

CINT

COEP

COSM

CVNA

CZOO

DOMO

ETNB

FTFT

GEVO

GOSS

GREE

HCTI

HLTH

ICPT

IPHA

LANV

Citigroup Financial 300% Minupon Princ Protected Nts for Russell 2000 Index

MDGL

MHUA

MINM

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

MOND

MRSN

MULN

NEPT

NEWP

NEXA

NOGN

OBSV

OTIC

PERF

PHGE

PRFX

QUMU

RDIB

RELL

RLAY

SCPS

SEER

SLNO

SMMT

SNPX

TELL

TERN

VANI

VKTX

VTGN

ZVSA

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session

<h3>The Meaning Behind Value Stocks</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Below is a list of notable value stocks in the communication services sector:</h2>
<ol>
<li>Thryv Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRY#NASDAQ">THRY</a>) - P/E: 6.43</li>
<li>Sinclair Broadcast Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBGI#NASDAQ">SBGI</a>) - P/E: 0.53</li>
<li>PLDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHI#NYSE">PHI</a>) - P/E: 9.87</li>
<li>Tegna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGNA#NYSE">TGNA</a>) - P/E: 8.25</li>
<li>DISH Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DISH#NASDAQ">DISH</a>) - P/E: 5.06</li>
</ol>
Thryv Holdings saw a decrease in earnings per share from 1.61 in Q2 to $0.37 now. This quarter, Sinclair Broadcast Group experienced an increase in earnings per share, which was $-0.03 in Q2 and is now $0.36. Most recently, the company reported a dividend yield of 5.41%, which has increased by 0.86% from last quarter's yield of 4.55%.
This quarter, PLDT experienced an increase in earnings per share, which was $0.67 in Q2 and is now $0.87. Its most recent dividend yield is at 8.77%, which has increased by 5.4% from 3.37% in the previous quarter.
Most recently, Tegna reported earnings per share at $0.65, whereas in Q2 earnings per share sat at $0.6. Its most recent dividend yield is at 1.82%, which has increased by 0.02% from 1.8% in the previous quarter.
DISH Network's earnings per share for Q3 sits at $0.65, whereas in Q2, they were at 0.82. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

DISH

SBGI

TGNA

THRY

Mr. Yat-Gai Au, chairman and CEO of Regencell Bioscience Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgc#NASDAQ">RGC</a>), is attracting a lot of press.
A quick search of Alphabet Inc.&rsquo;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) Google provides clues to some of his achievements, including his passion for helping others.
That passion may be the inspiration behind the birth of <a href="https://www.regencellbioscience.com/">Regencell Bioscience</a> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgc#NASDAQ">RGC</a>). Mr. Au&rsquo;s company prides itself as an early-stage bioscience company focused on the research, development and commercialization of traditional Chinese medicine (TCM).&nbsp;
According to the company, these medicines treat neurocognitive disorders and degenerations and infectious diseases affecting people&rsquo;s immune systems.&nbsp;
<h2>Who Is Yat-Gai Au?</h2>
After graduating with a bachelor&rsquo;s degree from the University of California, Berkeley&rsquo;s Haas School of Business, Mr. Au began his career in investment banking at Deutsche Bank AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) and ING Barings.
He has completed deals valued at more than $4 billion and won many prestigious merger and acquisitions (M&amp;A) awards, according to reports.
Notable deals include the $750 million acquisition of Philippine Long Distance Telephone &mdash; now PLDT Inc. ADR (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/phi#NYSE">PHI</a>), the $650 million acquisition of Indofood and the $1.8 billion secondary placement for 40% interest in Hagemeyer &mdash; all executed on behalf of First Pacific Company Limited (HKG: 0142).
<h2>Establishing Regencell Bioscience</h2>
Over the years, Mr. Au says he has witnessed patients recover from attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) through TCM treatments. He wondered why such beneficial treatments are only available to a small number of patients and believed that the formula should be more readily available in order to help people around the world.
He established Regencell in 2014 after seeing notable improvements in many cases, including close friends and family members who had shown ADHD and ASD symptoms.
<h2>Giving Back</h2>
Regencell CEO says he is passionate about participating in and funding charitable activities for the elderly, gifted students and the financially underprivileged. In 2017, he established Regencell Foundation to be able to give back to society. He was taught at an early age that giving back is one of the most fulfilling thing one can do to make the world a better place.&nbsp;
In 2020, during the early-days of the COVID-19 outbreak when face mask were scarce, he sourced and donated over 200,000 masks to hospitals, the elderly and needy families in Korea, Singapore, Vietnam, Malaysia, Hong Kong and the U.S.
Mr. Au also <a href="https://www.businesswire.com/news/home/20220516005619/en/Regencell-Bioscience-Holdings-Limited-Announces-Over-5-Million-Ordinary-Share-Purchases-by-CEO">disclosed</a> that he is spearheading a philanthropic project to provide grants to over 10,000 children afflicted with ADHD, ASD, COVID-19 and those in severe financial distress.
&ldquo;I started providing grants on April 16, 2022, and have already helped over 200 children,&rdquo; he said.
<h2>Supporting Company And Shareholders</h2>
To demonstrate his belief in the company, Mr. Au has been increasing his shareholdings in Regencell since Regencell&rsquo;s IPO. He has also recently <a href="https://www.businesswire.com/news/home/20220516005619/en/Regencell-Bioscience-Holdings-Limited-Announces-Over-5-Million-Ordinary-Share-Purchases-by-CEO">purchased</a> ordinary shares in Regencell.
Based on his Schedule 13D filings with the U.S. Securities and Exchange Commission between July 27, 2021, and July 25, 2022, he used an aggregate of $5.9 million of his personal funds to buy the shares through the open market.
According to the latest filing, Regencell CEO owns 10,561,594 ordinary shares, representing 81.2% of total issued and outstanding shares, following his recent purchases.&nbsp;
&ldquo;Short and distort schemes used on our stock are negatively affecting our company,&rdquo; Mr. Au said. &ldquo;These schemes hurt our investors and patients, especially children and their families who are looking for a natural approach to treat ADHD, and ASD and COVID-19. It can potentially disrupt our mission to help patients in need.&rdquo;
He said he agreed with Tesla Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) CEO Elon Musk that sophisticated hedge funds are using short-selling and complex derivatives to take advantage of small investors.
&ldquo;I will continue to draw a $1 annual salary and no bonus until the company reaches a $1 billion market capitalization and reserve share options for all employees except myself,&rdquo; Mr. Au said.
He pledged to continue to use his funds to purchase company shares to demonstrate his commitment to Regencell and his position against short and distort sellers.
With a total cumulative short volume of over 19 million shares since the company&rsquo;s initial public offering (IPO), Mr. Au says he began his share purchases last year using his personal funds to further the company&rsquo;s goal to save and improve lives.
Additionally, company directors and employees who were previously granted stock options upon the company&rsquo;s IPO have agreed to a further lockup undertaking for six months after their stock options become vested.
Since Regencell&#39;s incorporation in October 2014 up to the IPO, Mr. Au has fully <a href="https://www.benzinga.com/news/small-cap/22/06/27852402/rgc-ceo-figuratively-putting-his-money-where-his-mouth-is">funded</a> the company. Upon the IPO, his $3.25 million loan to the company was converted into approximately 342,000 common shares at an initial offering price of $9.50.
As we are going through an unprecedented time, people are trying to find innovative ways to reshape the world in a positive way. Mr. Au and Regencell have been practicing good corporate social responsibility (CSR) and are working towards an ESG framework by integrating its business and employees&rsquo; personal values to create a sustainable business for the future. Mr. Au&#39;s and the company&#39;s philanthropic endeavors have not gone unnoticed. His idea is simple: perseverance to do social good and surround yourself with like-minded individuals will inevitably create a successful company, and that starts with hiring the best people who contribute to society and share the same values, where their actions count and views matter.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Featured photo by <a href="https://twitter.com/NasdaqExchange/status/1416139158863679493/photo/1">Nasdaq Exchange</a>
&nbsp;

Biotech

General

GOOGL

TSLA

From Providing Grants To Over 10,000 Children With ADHD, ASD And COVID-19, To Building A Company To Save And Improve Lives, This CEO Could Be Taking Philanthropy To A New Level

KIND

LIZI

MDIA

SLGG

Shares of companies in the broader communications, media & entertainment industry are trading lower amid overall market weakness as investors assess the incoming results of U.S. midterm elections. Additionally, weakness from Walt Disney's Q4 earnings results has impacted the sector.

On August 5, 2021, PLDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHI#NYSE">PHI</a>) announced shareholders can expect to receive a dividend payable on September 20, 2021. The stock will then go ex-dividend 1 business day(s) before the record date. The ex-dividend date for PLDT will be on August 17, 2021. The company's current dividend payout is at $0.84. That equates to a dividend yield of 6.88% at current price levels. 
<h2>What Is An Ex-Dividend Date?</h2>
An ex-dividend date signals when a company's shares cease to trade with its current dividend payout. There is a small intermission period before the company announces a new dividend. Usually, a company's ex-dividend date falls one business day before its record date. Investors should keep this in mind when purchasing stocks because buying them on or after ex-dividend dates does not qualify them to receive the declared payment. Newly declared dividends go to shareholders who have owned that stock before the ex-dividend date. Typically, companies will announce and implement new dividend yields on a quarterly basis. 
<h2>Understanding PLDT's Dividend Payouts And Yields</h2>
Over the past year, PLDT has experienced an overall upward trend regarding its dividend payouts and yields. Last year on August 24, 2018 the company's payout was $0.67, which has since grown by $0.18. Similarly, PLDT's dividend yield in last year was 5.0%, which has since grown by 1.88%. 
Companies use dividend yields in different strategic ways. Some companies may opt to not give yields altogether to reinvest in themselves. Other companies may opt to increase or decrease their yield amounts to control how their shares circulate throughout the stock market. 
To read more news on PLDT <a href="https://www.benzinga.com/stock/phi/">click here</a>.

Dividends

Analyzing PLDT's Ex-Dividend Date

&nbsp;
<h1>&nbsp;</h1>
During Wednesday&#39;s morning trading, 47 companies set new 52-week lows.
<h2>Highlights:</h2>
<ul>
<li>CoStar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) was the biggest company in terms of market cap to set a new 52-week low.</li>
<li>Unique Fabricating (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UFAB#AMEX">UFAB</a>) is the smallest company on a market cap basis to set a new 52-week low.</li>
<li>Hoegh LNG Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMLP#NYSE">HMLP</a>)&#39;s stock traded down the lowest, falling 60.16% to reach a new 52-week low.</li>
</ul>
Stocks that set new 52-week lows during the first half-hour of trading on Wednesday are as follows:
<ul>
<li>CoStar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) shares set a new yearly low of $80.00 this morning. The stock was down 6.52% on the session.</li>
<li>PLDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHI#NYSE">PHI</a>) stock drifted down 0.51% on Wednesday morning to hit a new 52-week low of $24.39.</li>
<li>DigitalBridge Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBRG#NYSE">DBRG</a>) shares were down 0.6% for the day, having made a 52-week low of $6.64.</li>
<li>MorphoSys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOR#NASDAQ">MOR</a>) stock hit a new 52-week low of $13.21. The stock was down 0.22% on the session.</li>
<li>Wheels Up Experience (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) stock hit a yearly low of $7.10. The stock was down 2.56% for the day.</li>
<li>Heron Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) stock hit $12.19 on Wednesday morning, setting a new 52-week low for a change of up 0.33%.</li>
<li>Innoviz Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVZ#NASDAQ">INVZ</a>) stock hit a yearly low of $7.80. The stock was down 0.06% for the day.</li>
<li>Origin Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGN#NASDAQ">ORGN</a>) stock hit $6.29 on Wednesday morning, setting a new 52-week low for a change of up 1.26%.</li>
<li>CareMax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares were down 1.5% for the day, having made a 52-week low of $9.22.</li>
<li>SVF Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVFA#NASDAQ">SVFA</a>) stock hit a yearly low of $9.76. The stock was down 0.1% for the day.</li>
<li>Vital Farms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VITL#NASDAQ">VITL</a>) shares set a new yearly low of $17.68 this morning. The stock was up 1.01% on the session.</li>
<li>MSD Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSDA#NASDAQ">MSDA</a>) stock broke to a new 52-week low of $9.78 on Wednesday. Shares of the company traded down 0.46%.</li>
<li>LiveVox Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVOX#NASDAQ">LVOX</a>) stock achieved a new 52-week low on Wednesday morning, hitting $7.11 and moving down 3.18%.</li>
<li>Perella Weinberg Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) shares moved down 0.9% on Wednesday to hit a new 52-week low of $12.05, drifting down 0.9%.</li>
<li>FirstMark Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMAC#NYSE">FMAC</a>) stock drifted down 0.31% on Wednesday morning to hit a new 52-week low of $9.72.</li>
<li>Capitol Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAP#NYSE">CAP</a>) stock hit $8.80 on Wednesday morning, setting a new 52-week low for a change of down 0.14%.</li>
<li>FutureFuel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) stock broke to a new 52-week low of $8.35 on Wednesday. Shares of the company traded down 0.94%.</li>
<li>ION Acquisition Corp 3 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IACC#NYSE">IACC</a>) stock broke to a new 52-week low of $9.66 on Wednesday. Shares of the company traded up 0.31%.</li>
<li>Aerovate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTE#NASDAQ">AVTE</a>) shares moved up 0.97% on Wednesday to hit a new 52-week low of $12.66, drifting up 0.97%.</li>
<li>Real Brokerage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) stock set a new 52-week low of $1.77 on Wednesday, moving down 0.2%.</li>
<li>Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) stock broke to a new 52-week low of $8.76 on Wednesday. Shares of the company traded down 2.09%.</li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock achieved a new 52-week low on Wednesday morning, hitting $9.01 and moving up 0.33%.</li>
<li>NexImmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXI#NASDAQ">NEXI</a>) stock broke to a new 52-week low of $10.12 on Wednesday. Shares of the company traded up 3.47%.</li>
<li>Hoegh LNG Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMLP#NYSE">HMLP</a>) stock hit a yearly low of $6.56. The stock was down 60.16% for the day.</li>
<li>Heritage Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>) shares set a new yearly low of $7.20 this morning. The stock was down 1.97% on the session.</li>
<li>Spok Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPOK#NASDAQ">SPOK</a>) shares set a new 52-week low of $7.80. The stock traded down 7.37%.</li>
<li>European Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAC#NASDAQ">EBAC</a>) shares made a new 52-week low of $9.60 on Wednesday. The stock was down 0.52% for the day.</li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) stock hit a yearly low of $5.95. The stock was down 2.08% for the day.</li>
<li>Erytech Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERYP#NASDAQ">ERYP</a>) stock hit a new 52-week low of $4.20. The stock was down 8.26% on the session.</li>
<li>InflaRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFRX#NASDAQ">IFRX</a>) stock hit a yearly low of $2.39. The stock was up 1.21% for the day.</li>
<li>Ucommune International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UK#NASDAQ">UK</a>) stock achieved a new 52-week low on Wednesday morning, hitting $0.98 and moving down 7.98%.</li>
<li>CooTek (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTK#NYSE">CTK</a>) stock achieved a new 52-week low on Wednesday morning, hitting $1.37 and moving down 1.77%.</li>
<li>IRSA Propiedades (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRCP#NASDAQ">IRCP</a>) stock hit $2.69 on Wednesday morning, setting a new 52-week low for a change of down 8.3%.</li>
<li>Yumanity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YMTX#NASDAQ">YMTX</a>) shares set a new 52-week low of $8.24. The stock traded down 1.39%.</li>
<li>Vivos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVOS#NASDAQ">VVOS</a>) shares set a new 52-week low of $3.21. The stock traded down 5.25%.</li>
<li>Metacrine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCR#NASDAQ">MTCR</a>) shares fell to $2.70 on Wednesday, setting a new 52-week low with a shift of up 1.39%.</li>
<li>Scopus BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPS#NASDAQ">SCPS</a>) shares made a new 52-week low of $4.46 on Wednesday. The stock was up 0.22% for the day.</li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) shares fell to $7.71 on Wednesday, setting a new 52-week low with a shift of down 2.13%.</li>
<li>Avalon Globocare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVCO#NASDAQ">AVCO</a>) stock hit a yearly low of $0.80. The stock was up 0.17% for the day.</li>
<li>Sentage Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTG#NASDAQ">SNTG</a>) stock hit a new 52-week low of $4.36. The stock was up 0.66% on the session.</li>
<li>Lumos Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUMO#NASDAQ">LUMO</a>) shares hit a yearly low of $7.55. The stock was down 0.26% on the session.</li>
<li>Alset EHome International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEI#NASDAQ">AEI</a>) shares fell to $2.19 on Wednesday, setting a new 52-week low with a shift of down 35.19%.</li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares set a new 52-week low of $2.35. The stock traded down 4.28%.</li>
<li>G Medical Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMVD#NASDAQ">GMVD</a>) stock drifted down 2.51% on Wednesday morning to hit a new 52-week low of $2.32.</li>
<li>Inspira Technologies Oxy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IINN#NASDAQ">IINN</a>) stock achieved a new 52-week low on Wednesday morning, hitting $3.71 and moving down 4.34%.</li>
<li>China XD Plastics Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDC#NASDAQ">CXDC</a>) stock drifted down 0.27% on Wednesday morning to hit a new 52-week low of $0.40.</li>
<li>Unique Fabricating (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UFAB#AMEX">UFAB</a>) shares set a new yearly low of $2.50 this morning. The stock was down 2.72% on the session.</li>
</ul>
&nbsp;
Benzinga will continue to update investors on 52-week lows hit in these and other stocks. Stay tuned!

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

PLDT

PLDT (PHI) Forecast

PLDT (NYSE:PHI) Stock, Quote.Headers.trade-ideas